Objectives Biosimilar market launch delays are likely costing healthcare systems billions of
dollars and preventing patients accessing affordable biologic therapies sooner. Many claim …

Litigated pharmaceutical patents are a valuable source of data on how much inventiveness
is required for a patent grant and what are the costs of patents. Although innovation is …

ABSTRACT In 2011, National Treasury proposed the introduction of the Twin Peaks
regulatory model for the South African financial sector. The adoption of this model will …

This paper shows that economic recessions result from a scarcity of product innovations
attributable to the flawed balanced approach of the current patent system. While rejecting …

This paper considers geographic indications (GIs) from both the European terroir
perspective and the New World heritage perspective. Consumer protection rationales are …

New generation trade agreements reach far behind borders, affecting many areas of
domestic policy not previously associated closely with trade. One of the most uneasy of …

Patents were originally designed to encourage technological innovation, which would not
otherwise occur, and which create spillover benefits. Careful design is needed to ensure …

Innovation policy promotes patenting by basic researchers-Are patents prohibitive rights that
contradict the ideal of open science, or do scientific communities succeed in adapting the …

According to the previous chapter, economic recessions result from innovation scarcity.
Since patent laws are supposed to stimulate innovations, the scarcity of innovation reflects …